Orthopaedics
Thiazolidinediones and Fracture Risks
Oral glucose-lowering drugs belonging to thiazolidinediones decrease osteoblastic activity and recent trials have suggested the possibility that they increase the fracture risk.
Read more
http://mn.medsurfnews.com/contents/en/2552/display/thiazolid...
MedNews